Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follitropin Delta in Long GnRH Agonist vs Antagonist Protocols for IVF
NCT03809429Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2019
- Primary completion
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of follitropin delta in female infertility, sponsored by Ferring Pharmaceuticals. Started Apr 2019; status: completed.
02
Drugs
follitropin delta
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03809429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809429.